We are live on ! Find out more
OBCI

Ocean Bio-Chem Inc

Delisted

OBCI was delisted on the 8th of August, 2022.

23 hedge funds and large institutions have $14.3M invested in Ocean Bio-Chem Inc in 2020 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

505% more capital invested

Capital invested by funds: $2.37M → $14.3M (+$12M)

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

300% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 2

44% more funds holding

Funds holding: 1623 (+7)

Holders
23
Holders Change
+7
Holders Change %
+43.75%
% of All Funds
0.47%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
8
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change

OBCI Hedge Fund Activity: Q2 2020 in Review

23 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Ocean Bio-Chem Inc (OBCI) for Q2 2020, worth a combined $14.3M — up 505% from $2.37M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new OBCI positions and 2 closed out — a net gain of 8 holders — while 8 added to existing stakes and 2 trimmed.

The largest buyer was Worth Venture Partners, opening a new position worth an estimated $1.21M. The largest seller was Essex Investment Management, cutting an estimated $371K.

  • 23 institutional investors held Ocean Bio-Chem Inc (OBCI) as of Q2 2020, up from 16 in Q1 2020.
  • Funds reported $14.3M of Ocean Bio-Chem Inc stock for Q2 2020, up 505% quarter-over-quarter.
  • 10 funds opened new Ocean Bio-Chem Inc positions in Q2 2020 and 2 closed out, a net change of +8 holders.
  • The largest Ocean Bio-Chem Inc buyer in Q2 2020 was Worth Venture Partners, an estimated $1.21M added.
  • The largest Ocean Bio-Chem Inc seller in Q2 2020 was Essex Investment Management, an estimated $371K sold.

Based on aggregated 13F filings for Q2 2020.